Dermal absorption of camphor, menthol, and methyl salicylate in humans

Journal of Clinical Pharmacology

Volumn 44, Issue 10, 2004, Pages 1151-1157

  Martin, Debra ^a   Valdez, Jennifer ^b   Boren, James ^c   Mayersohn, Michael ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b Laboratory Division   (United States)

^c RADIANT RESEARCH   (United States)

Author keywords

Absorption; Camphor; Dermal patches; Menthol; Methyl salicylate; Toxicity

Indexed keywords

CAMPHOR; MENTHOL; SALICYLIC ACID METHYL ESTER;

ADULT; ARTICLE; BIOAVAILABILITY; BLOOD LEVEL; DRUG EXPOSURE; DRUG FORMULATION; FEMALE; GAS CHROMATOGRAPHY; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; SKIN ABSORPTION; TIME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CAMPHOR; FEMALE; HUMANS; LINEAR MODELS; MALE; MENTHOL; MIDDLE AGED; SALICYLATES; SKIN ABSORPTION;

EID: 4444265322     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270004268409     Document Type: Article

References (19)

1. Valdez JS, Martin DK, Mayersohn M. Sensitive and selective gas Chromatographic methods for the quantitation of camphor, menthol, and methyl salicylate from human plasma. J Chromatogr Biomed Sci Appl. 1999;729:163-171.
2. Committee on Drugs, 1992-1993. Camphor revisited: focus on toxicity. Pediatrics. 1994;94:127-128.
3. Mascie-Taylor BH, Widdop B, Davison AM. Camphor intoxication treated by charcoal haemoperfusion. Postgrad Med J 1981;57:725-726.
4. Siegel E, Wason S. Camphor toxicity. Pediatr Clin North Am. 1986;33:375-379.
5. Phelan WJ III. Camphor poisoning: over-the-counter dangers. Pediatrics. 1976;57:428-431.
6. Gibson DE, Moore GP, Pfaff JA. Camphor ingestion. Am J Emergency Med. 1989;7:41-43.
7. Thienes CH, Haley TJ, eds. Clinical Toxicology. 5th ed. Philadelphia: Lea & Febiger, 1972.
8. Rabl W, Katzgraber F, Steinlechner M. Camphor ingestion for abortion [case report]. Forensic Sci Int. 1997;89:137-140.
9. Jimenez JF, Brown AL, Arnold WC, Byrne WJ. Chronic camphor ingestion mimicking Reye's syndrome. Gastroenterology. 1983;84:394-398.
10. Wilkinson SM, Beck MH. Allergic contact dermatitis from menthol in peppermint. Contact Dermatitis. 1994:30:42-43.
11. Aguirre A, Oleaga JM, Zabala R, Izu R, Díaz-Pérez JL. Allergic contact dermatitis from Reflex spray. Contact Dermatitis. 1994;30:52-53.
12. Morton CA, Garioch J, Todd P, Lamey PJ, Forsyth A. Contact sensitivity to menthol and peppermint in patients with intra-oral symptoms. Contact Dermatitis. 1995:32:281-284.
13. McGowan EM. Menthol urticaria. Arch Dermatol. 1966;94:62-63.
14. Heng MCY. Local necrosis and interstitial nephritis due to topical methyl salicylate and menthol. Cutis. 1987;39:442-444.
15. Gosselin RE, Hodge CH, Smith RP, Gleason MN, eds. Clinical Toxicology of Commercial Products, Acute Poisoning. 4th ed. Baltimore: Williams & Wilkins, 1976.
16. Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med. 1998;16:443-497.
17. Yano T, Kanetake T, Saita M, Noda K. Effects of 7-menthol and dl-camphor on the penetration and hydrolysis of methyl salicylate in hairless mouse skin. J Pharmacobiodyn. 1991;14:663-669.
18. Lam FC, Hung CT, Perrier DG. Estimation of variance for harmonic mean half-lives. J Pharm Sci. 1986;74:229-231.
19. Gelal A, Jacob P III, Benowitz NL. Disposition kinetics and effects of menthol. Clin Pharmacol Ther. 1999;66:128-135.